BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32868522)

  • 1. The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study.
    Kanahara N; Takase M; Sasaki T; Honma M; Fujita Y; Tadokoro S; Suzuki H; Yamanaka H; Noda S; Yanahashi S; Saiga T; Komatsu N; Simoyama T; Iyo M
    Int Clin Psychopharmacol; 2020 Nov; 35(6):338-344. PubMed ID: 32868522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.
    Takase M; Kanahara N; Oda Y; Kimura H; Watanabe H; Iyo M
    J Psychopharmacol; 2015 Apr; 29(4):383-9. PubMed ID: 25735995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice.
    Nakata Y; Kanahara N; Iyo M
    J Psychopharmacol; 2017 Dec; 31(12):1511-1518. PubMed ID: 28925317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case series on aripiprazole and dopamine supersensitivity psychosis.
    Russell G; Reinfeld S; Kam O; Lee G; Weiss M; Koola MM
    Int Clin Psychopharmacol; 2022 May; 37(3):122-128. PubMed ID: 35143441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia.
    Nakata Y; Kanahara N; Kimura H; Watanabe H; Iyo M
    Int Clin Psychopharmacol; 2017 May; 32(3):169-173. PubMed ID: 28067751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy.
    Chouinard G; Samaha AN; Chouinard VA; Peretti CS; Kanahara N; Takase M; Iyo M
    Psychother Psychosom; 2017; 86(4):189-219. PubMed ID: 28647739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up.
    Kimura H; Kanahara N; Sasaki T; Komatsu N; Ishige M; Muneoka K; Ino H; Yoshimura K; Yamanaka H; Suzuki T; Komatsu H; Watanabe H; Shimizu E; Iyo M
    J Psychopharmacol; 2016 Aug; 30(8):795-802. PubMed ID: 27371496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aripiprazole as dopamine partial agonist model: Basic concepts and clinical impact].
    Simon N; Azorin JM
    Encephale; 2018 Dec; 44(6):558-564. PubMed ID: 30466778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia.
    Suzuki T; Kanahara N; Yamanaka H; Takase M; Kimura H; Watanabe H; Iyo M
    Psychiatry Res; 2015 Jun; 227(2-3):278-82. PubMed ID: 25863824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia.
    Oda Y; Kanahara N; Iyo M
    Int J Mol Sci; 2015 Dec; 16(12):30144-63. PubMed ID: 26694375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.
    Takekita Y; Fabbri C; Kato M; Nonen S; Sakai S; Sunada N; Koshikawa Y; Wakeno M; Okugawa G; Kinoshita T; Serretti A
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):579-88. PubMed ID: 26016467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia.
    Kanahara N; Kimura H; Oda Y; Ito F; Iyo M
    Curr Neuropharmacol; 2021; 19(12):2214-2226. PubMed ID: 33550976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice.
    Yamasaki F; Kanahara N; Nakata Y; Koyoshi S; Yanagisawa Y; Saito T; Oiwa T; Kogure M; Sasaki T; Yoshida T; Kimura H; Iyo M
    J Psychopharmacol; 2023 Oct; 37(10):992-1002. PubMed ID: 37395368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of modified electroconvulsive therapy and long-acting injectable aripiprazole for dopamine supersensitivity psychosis: a case report.
    Matsuzaka Y; Noguchi M; Kanamura S; Maeda K; Hisano T; Tanaka D; Ando Y; Yamamoto T; Morimoto Y; Ozawa H; Otsuka T
    Neurocase; 2022 Jun; 28(3):310-313. PubMed ID: 35993136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis.
    Tadokoro S; Okamura N; Sekine Y; Kanahara N; Hashimoto K; Iyo M
    Schizophr Bull; 2012 Sep; 38(5):1012-20. PubMed ID: 21402722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of electroconvulsive therapy and aripiprazole for dopamine supersensitivity psychosis.
    Kanahara N; Hirabayashi M; Mamada T; Nishimoto M; Iyo M
    Schizophr Res; 2018 Dec; 202():398-400. PubMed ID: 29937327
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-Term Treatment With Long-Acting Injectable Antipsychotic in Schizophrenia Patients With and Without Dopamine Supersensitivity Psychosis: A 6-Year Retrospective Comparative Study.
    Kogure M; Kanahara N; Kimura M; Hanaoka S; Hirano H; Iyo M
    J Clin Psychopharmacol; 2022 Jul-Aug 01; 42(4):357-364. PubMed ID: 35727084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two Cases.
    Kanahara N; Kimura H; Kinoshita T; Iyo M; Takekita Y
    Clin Psychopharmacol Neurosci; 2023 Feb; 21(1):197-201. PubMed ID: 36700326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repeated electroconvulsive shocks on dopamine supersensitivity psychosis model rats.
    Kimura M; Oda Y; Oishi K; Yoshino K; Kimura H; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
    Schizophr Res; 2021 Feb; 228():1-6. PubMed ID: 33429150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.